NSCLC Stage IV
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
4 drugs in development·1 company·4 clinical trials
Drug Pipeline by Phase
Phase 3(3)
Phase 1(1)
| Drug | Company |
|---|---|
| N-803 | ImmunityBio, Inc. (IBRX) |
Compare drugs
Frequently asked questions
How many drugs are in development for NSCLC Stage IV?
BioSniper tracks 4 drugs in development for NSCLC Stage IV across 1 company.
How many clinical trials target NSCLC Stage IV?
There are 4 clinical trials targeting NSCLC Stage IV tracked by BioSniper.
Deep-dive into NSCLC Stage IV
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis